Hurone AI has entered into a strategic know-how agreement to license Mayo Clinic’s HOUSES technology into its cancer navigation platform, aiming to improve patient outcomes by addressing social determinants of health. The collaboration embeds the housing-based socioeconomic metric directly into Hurone’s oncology ecosystem, allowing clinical teams to identify and support patients facing non-biological barriers such as food insecurity, transportation challenges, and financial toxicity.
Understanding the HOUSES Metric in Oncology
The HOUSES (HOUsing-based index of Socioeconomic Status) technology is a validated tool designed to assess an individual’s socioeconomic standing based on specific housing characteristics. Unlike traditional models that rely on broad zip-code averages, the HOUSES system provides a granular, individual-level measurement of social risk. This metric has been clinically validated to predict more than 70 distinct health outcomes, serving as a robust statistical instrument for clinical risk stratification.
By incorporating this data into the Hurona platform, Hurone AI moves beyond clinical data to account for the environmental and financial pressures that often impact treatment adherence. For oncology patients, these factors are frequently as critical as the biological markers of their disease. The system automatically flags patients at higher risk for falling behind on treatment protocols, enabling providers to initiate proactive interventions.
Integrating Social Intelligence into Clinical Workflows
A primary challenge in modern oncology is the high administrative burden placed on clinical staff. Hurone AI addresses this by ensuring its platform integrates natively into the Epic EHR. Because the technology writes directly back to native clinical views, oncology teams can monitor social risk markers without the need to toggle between different software portals or interrupt their standard documentation workflows.
Dr. Kingsley I. Ndoh, Founder and CEO of Hurone AI, emphasized the necessity of addressing the “whole person” in cancer care. “Cancer outcomes are determined not only by biology and treatment, but by the social and economic circumstances patients navigate every day,” Dr. Ndoh stated. By automating the identification of social vulnerabilities, the platform allows care teams to bridge gaps by connecting patients with localized resources, such as non-emergency medical transportation or financial assistance programs, at the exact moment a need is identified.
Addressing Health Disparities Through Data
The deployment of this technology across academic medical centers aims to reduce health disparities by automating the complex navigation required for long-term survivorship. The platform functions as a “clinical and social co-pilot,” providing patients with structured education and 24/7 symptom management guidance while simultaneously triaging administrative tasks in the background.
By shifting the focus toward proactive resource matching, health systems can better manage patient populations despite current clinical staffing shortages. The integration of the HOUSES index ensures that social risk is not treated as an afterthought but as a central component of the personalized, equitable care model that modern oncology centers are striving to implement. As these systems continue to scale, the focus remains on streamlining the transition from initial diagnosis to long-term care, ensuring that administrative friction does not impede the delivery of high-quality, patient-centered oncology services.
For further updates on the implementation of this technology within oncology networks, stakeholders and providers are encouraged to follow official announcements from Hurone AI.